Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,253 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,463
Recruiting: 820
Ph III recruiting: 96
Growth YoY: +6.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 551–581 of 581 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06128460	Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer.	not yet recruiting	Phase 2	24	Obstetrics & Gynecology Hospital of Fudan UniversityOTHER	0	Nov 30, 2023	clinicaltrials
NCT06149767	Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer	not yet recruiting	Phase 2	26	Fujian Cancer HospitalOTHER_GOV	0	Nov 29, 2023	clinicaltrials